NDC 0069-1542 – Doxorubicin Hydrochloride
Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Intravenous
Product NDC0069-1542
Product details
- Brand name
- Doxorubicin Hydrochloride
- Generic name
- Doxorubicin Hydrochloride
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- NDA · NDA050629
- Marketed since
- July 22, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Anthracycline Topoisomerase Inhibitor
Active ingredients
- Doxorubicin Hydrochloride 2 mg/mL
Uses, dosage, side effects and warnings for Doxorubicin Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0069-1542-20 | 1 VIAL, MULTI-DOSE in 1 CARTON (0069-1542-20) / 100 mL in 1 VIAL, MULTI-DOSE | Jul 22, 2024 |
Other Doxorubicin Hydrochloride products
- 45963-733 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Actavis Pharma, Inc.
- 63323-101 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 63323-883 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 68083-248 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Gland Pharma Limited
- 68083-249 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Gland Pharma Limited
- 68083-250 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Gland Pharma Limited
- 0143-9091 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9089 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9084 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9085 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9086 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9087 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.